24338-155 : Danziten 95 mg Oral Tablet


NDC: 24338-155
Labeler: Azurity Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Danziten
Dosage Form: Oral Tablet
Application #: NDA219293
Rev. Date: 


NDC Package Codes:

  • 24338-155-01: 4 CARTON IN 1 CARTON (24338‑155‑01) / 2 BLISTER PACK IN 1 CARTON (24338‑155‑02) / 14 TABLET IN 1 BLISTER PACK (24338‑155‑03)

Active Ingredients:

  • Nilotinib

Dosage Strength:

  • 95 mg

Pharmaceutical Classes:

  • Bcr-Abl Tyrosine Kinase Inhibitors [MoA]
  • Cytochrome P450 2B6 Inducers [MoA]
  • Cytochrome P450 2C8 Inducers [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Kinase Inhibitor [EPC]
  • P-Glycoprotein Inhibitors [MoA]
  • UGT1A1 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 24338-154 Danziten 71 mg Oral Tablet by Azurity Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 24338-155 QR Code

< Prev: 24338-154Next: 24338-183 >

Related Discussions:

Tasigna (Nilotinib) Availability
Please help. My husband has been diagnosed with CML. He was prescribed Tasigna by his doctor. My problem is there is no ...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.